Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers are beneficial in normotensive atherosclerotic patients: a collaborative meta-analysis of randomized trials
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.